Literature DB >> 24023450

Topiramate: Safety in migraine patients.

M Ahamada Safna Mariyam1, Suchandra Sen, K Vijayan.   

Abstract

Entities:  

Year:  2013        PMID： 24023450      PMCID： PMC3758093          DOI： 10.1016/j.jyp.2012.12.001

Source DB:  PubMed          Journal:  J Young Pharm        ISSN： 0975-1483


× No keyword cloud information.
  6 in total

1.  Topiramate weight loss in migraine patients.

Authors:  Antonella Alberici; Barbara Borroni; Filippo Manelli; Simona Griffini; Paola Zavarise; Alessandro Padovani; Giorgio Dalla Volta
Journal:  J Neurol Sci       Date:  2008-12-13       Impact factor: 3.181

Review 2.  Molecular pharmacology of topiramate: managing seizures and preventing migraine.

Authors:  H Steve White
Journal:  Headache       Date:  2005-04       Impact factor: 5.887

3.  Topiramate: a case series study in migraine prophylaxis.

Authors:  W B Young; M M Hopkins; A L Shechter; S D Silberstein
Journal:  Cephalalgia       Date:  2002-10       Impact factor: 6.292

4.  Efficacy and safety of topiramate for the treatment of chronic migraine: a randomized, double-blind, placebo-controlled trial.

Authors:  Stephen D Silberstein; Richard B Lipton; David W Dodick; Frederick G Freitag; Nabih Ramadan; Ninan Mathew; Jan L Brandes; Marcelo Bigal; Joel Saper; Steven Ascher; Donna M Jordan; Steven J Greenberg; Joseph Hulihan
Journal:  Headache       Date:  2007-02       Impact factor: 5.887

5.  Topiramate reduces headache days in chronic migraine: a randomized, double-blind, placebo-controlled study.

Authors:  H-C Diener; G Bussone; J C Van Oene; M Lahaye; S Schwalen; P J Goadsby
Journal:  Cephalalgia       Date:  2007-04-18       Impact factor: 6.292

6.  Topiramate and the vision: a systematic review.

Authors:  Mohammad-Ali Abtahi; Seyed-Hossein Abtahi; Farhad Fazel; Peyman Roomizadeh; Masoud Etemadifar; Keivan Jenab; Mojtaba Akbari
Journal:  Clin Ophthalmol       Date:  2012-01-12
  6 in total
  1 in total

1.  Topiramate-induced paresthesia is more frequently reported by migraine than epileptic patients.

Authors:  Behnaz Sedighi; Kaveh Shafiei; Iman Azizpour
Journal:  Neurol Sci       Date:  2016-01-25       Impact factor: 3.307
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.